Yijia Group Implements 1-for-3 Reverse Split, Changes Name, and Designates High-Voting Preferred Stock

summarizeZusammenfassung

Yijia Group Corp. has undertaken a significant corporate restructuring, including a 1-for-3 reverse stock split and a name change to VitaNova Life Sciences Corporation. While the name change may signal a strategic pivot, the reverse stock split is often viewed negatively by the market. Most notably, the designation of 3,000,000 shares of Series A Preferred Stock, each carrying 20 votes and convertible 1-for-1 into common stock, represents a substantial shift in corporate control and significant potential dilution of voting power for existing common shareholders. Investors should carefully assess the implications of these governance changes and the potential for future capital raises under the new capital structure.

check_boxSchlusselereignisse

• Reverse Stock Split Implemented

  The company effected a 1-for-3 reverse stock split on January 9, 2026, which will reduce the number of outstanding common shares and increase the per-share price.

• Name Change to VitaNova Life Sciences Corporation

  Yijia Group Corp. officially changed its name to VitaNova Life Sciences Corporation, signaling a potential strategic shift in its business focus.

• Designation of High-Voting Preferred Stock

  3,000,000 shares of Series A Preferred Stock were designated, each carrying 20 votes per share and convertible 1-for-1 into common stock, significantly impacting common shareholder voting power and creating potential future dilution.

• Increased Authorized Capital

  The company previously increased its authorized capital to 200 million common shares and 10 million preferred shares, providing capacity for future equity issuances.

auto_awesomeAnalyse

Yijia Group Corp. has undertaken a significant corporate restructuring, including a 1-for-3 reverse stock split and a name change to VitaNova Life Sciences Corporation. While the name change may signal a strategic pivot, the reverse stock split is often viewed negatively by the market. Most notably, the designation of 3,000,000 shares of Series A Preferred Stock, each carrying 20 votes and convertible 1-for-1 into common stock, represents a substantial shift in corporate control and significant potential dilution of voting power for existing common shareholders. Investors should carefully assess the implications of these governance changes and the potential for future capital raises under the new capital structure.